CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer

International Journal of Molecular Medicine

Volumn 26, Issue 2, 2010, Pages 241-247

  Matsumoto, Mitsugi ^a   Kawakami, Kazumori ^a   Enokida, Hideki ^a   Toki, Kazuki ^a   Matsuda, Ryoichiro ^a   Chiyomaru, Takeshi ^a   Nishiyama, Kenryu ^a   Kawahara, Kazuya ^b   Seki, Naohiko ^c   Nakagawa, Masayuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kawahara Nephro urology Clinic   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; FHL1; Methylation; Microarray

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; AZACITIDINE; ENZYME INHIBITOR; FHL1 PROTEIN, HUMAN; LIM PROTEIN; MUSCLE PROTEIN; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; FOCAL ADHESION; FOUR AND A HALF LIM DOMAINS 1 GENE; GENE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING; BLADDER TUMOR; CELL MOTION; CELL PROLIFERATION; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AZACITIDINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; MALE; MIDDLE AGED; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 77955764475     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000458     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Mitra AP, Datar RH and Cote RJ: Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24: 5552-5564, 2006.
3. Kawakami K, Enokida H, Tachiwada T, et al: Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 16: 521-531, 2006.
4. Mori K, Enokida H, Kagara I, et al: CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer. Int J Oncol 34: 1593-1602, 2009.
5. Johannessen M, Moller S, Hansen T, et al: The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 63: 268-284, 2006.
6. Morgan MJ, Madgwick AJ, Charleston B, et al: The developmental regulation of a novel muscle LIM-protein. Biochem Biophys Res Commun 212: 840-846, 1995.
7. Brown S, McGrath MJ, Ooms LM, et al: Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. J Biol Chem 274: 27083-27089, 1999.
8. Oku N, Sasabe E, Ueta E, et al: Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 c2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 66: 5251-5257, 2006. (Pubitemid 43844949)
9. Shen Y, Jia Z, Nagele RG, et al: Src uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res 66: 1543-1552, 2006.
10. Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98: 13790-13795, 2001.
11. Fryknäs M, Wickenberg-Bolin U, Göransson H, et al: Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumor Biol 27: 211-220, 2006.
12. Sakashita K, Mimori K, Tanaka F, et al: Clinical significance of loss of Fhl1 expression in human gastric cancer. Ann Surg Oncol 15: 2293-2300, 2008.
13. Li X, Jia Z, Shen Y, Ichikawa H, Jarvik J, Nagele RG and Goldberg GS: Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Sci 99: 1326-1333, 2008. (Pubitemid 351761720)
14. Enokida H and Nakagawa M: Epigenetics in bladder cancer. Int J Clin Oncol 13: 298-307, 2008.
15. Lin HH, Ke HL, Huang SP, et al: Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Urol Oncol (In press).
16. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours, 6th edition. International Union Against Cancer (UICC). Wiley-Liss Publications, New York, 2002.
17. Ding L, Wang Z, Yan J, et al: Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β-like signaling pathway. J Clin Invest 119: 349-361, 2009.
18. Samson T, Smyth N, Janetzky S, et al: The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor. J Biol Chem 279: 28641-28652, 2004.
19. Coghill ID, Brown S, Cottle DL, et al: FHL3 is an actin-binding protein that regulates alpha-actinin-mediated actin bundling: FHL3 localizes to actin stress fibers and enhances cell spreading and stress fiber disassembly. J Biol Chem 278: 24139-24152, 2003.
20. Müller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R and Schüle R: The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 21: 736-748, 2002.
21. Martin B, Schneider R, Janetzky S, et al: The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J Cell Biol 159: 113-122, 2002.
22. Labalette C, Renard CA, Neuveut C, Buendia MA and Wei Y: Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin. Mol Cell Biol 24: 10689-10702, 2004.
23. Shi Y, Chen JY, Yang J, Li B, Chen ZH and Xiao CG: DBC2 gene is silenced by promoter methylation in bladder cancer. Urol Oncol 26: 465-469, 2008.
24. Ding L, Niu C, Zheng Y, et al: FHL1 interacts with estrogen receptors and regulates breast cancer cell growth. J Cell Mol Med (In press).
25. Lin J, Ding L, Jin R, et al: Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140 kDa (RIP140) interact and cooperate in estrogen signaling. Int J Biochem Cell Biol 41: 1613-1618, 2009.
26. Teng J, Wang ZY, Jarrard DF and Bjorling DE: Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Endocr Relat Cancer 15: 351-364, 2008. (Pubitemid 351449753)
27. Shen SS, Smith CL, Hsieh JT, et al: Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106: 2610-2616, 2006.